Cellvation, Inc
Cellvation, Inc. is a clinical-stage biopharmaceutical company based in New York, NY, dedicated to developing innovative cellular therapeutics for the treatment of traumatic brain injury (TBI). With a focus on regenerative medicine, Cellvation aims to provide novel therapies that address the complex challenges associated with TBI.
As a subsidiary of Fortress Biotech, Cellvation is at the forefront of cutting-edge research and development in the field of TBI treatment. The company's pipeline includes promising candidates such as CEVA102 and CEVA-D, which have shown potential in clinical trials, offering hope for improved outcomes and quality of life for TBI patients.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.